Bcl-2 Monoclonal Antibody(6B5)

This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.

Introducing the BCL-2 Monoclonal Antibody (6B5), a cutting-edge product designed to revolutionize the field of biomedical research. This highly specialized antibody is meticulously engineered to target and detect the BCL-2 protein, a key regulator of apoptosis. With its exceptional specificity and sensitivity, the BCL-2 Monoclonal Antibody (6B5) offers unparalleled accuracy in identifying and quantifying BCL-2 expression levels in various biological samples.

Crafted with utmost precision, the BCL-2 Monoclonal Antibody (6B5) exhibits exceptional affinity towards the BCL-2 protein, ensuring reliable and reproducible results. Its advanced monoclonal technology guarantees minimal cross-reactivity, enabling researchers to confidently explore the intricate mechanisms underlying apoptosis and its dysregulation in various diseases.

This groundbreaking antibody is meticulously validated through rigorous quality control measures, ensuring its consistent performance and reliability. Its exceptional stability and long shelf life make it an indispensable tool for laboratories and research institutions worldwide.

The BCL-2 Monoclonal Antibody (6B5) is supplied in a convenient and user-friendly format, allowing for seamless integration into existing experimental protocols. Its versatility enables a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry, empowering researchers to delve deeper into the intricate workings of BCL-2 and its implications in disease pathogenesis.

In summary, the BCL-2 Monoclonal Antibody (6B5) represents a breakthrough in biomedical research, offering unparalleled specificity, sensitivity, and reliability. With its exceptional performance and versatility, this antibody is poised to revolutionize the understanding of apoptosis and pave the way for novel therapeutic interventions.